Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Assertio Holdings
AddedMar 19, 2024
UpdatedJul 16, 2026
Assertio Holdings

Assertio Holdings

Public

Innovative Newark-based pharmaceutical company developing orphan drugs and therapeutic solutions for US patients.

HQ
Newark, CA, US
Founded
2020
Overview
Compare
Fundraising
Employees

Assertio Holdings is a Newark-based pharmaceutical company dedicated to developing and commercializing innovative therapeutic solutions, including orphan drugs, primarily aimed at treating pain and other medical conditions. The company focuses on addressing unmet medical needs for patients in the United States.

Assertio Holdings has made significant strides in the pharmaceutical industry, contributing to advancements in pain management and rare disease treatments. Their impactful work has garnered attention and support from various stakeholders, enhancing their reputation as a leader in specialty pharmaceuticals.

Assertio Holdings - Similar Companies

Auxilius Pharma logo

Auxilius Pharma

auxiliuspharma.com

Accuitis logo

Accuitis

accuitis.com

Eton Pharmaceuticals logo

Eton Pharmaceuticals

Harmony Biosciences logo

Harmony Biosciences

Aquestive Therapeutics logo

Aquestive Therapeutics

aquestive.com

Manhattan Pharmaceuticals logo

Manhattan Pharmaceuticals

PleoPharma logo

PleoPharma

pleopharma.com

PTC Therapeutics logo

PTC Therapeutics

ptcbio.com

OurPharma Holdings logo

OurPharma Holdings

ourpharma.net

Chiesi USA logo

Chiesi USA

chiesi.com

Argentis Pharmaceuticals logo

Argentis Pharmaceuticals

argentisrx.com

Concours Pharmaceuticals logo

Concours Pharmaceuticals

NeuroTherapeutics Pharma logo

NeuroTherapeutics Pharma

Astria Therapeutics logo

Astria Therapeutics

astriatx.com

Orphan Star Therapeutics logo

Orphan Star Therapeutics

Assertio Holdings - Quick Facts

Who are Assertio Holdings' competitors?

Companies similar to Assertio Holdings include Auxilius Pharma, Accuitis, Eton Pharmaceuticals and Harmony Biosciences.

When was Assertio Holdings founded?

Assertio Holdings was founded in 2020.

Where is Assertio Holdings' headquarters located?

Assertio Holdings' headquarters is located in Newark, CA, US.

When was Assertio Holdings' last funding round?

Assertio Holdings' most recent funding round was for $60M (USD) in August 2022.

How much has Assertio Holdings raised to-date?

As of Aug 22, 2022, Assertio Holdings has raised a total of $1B (USD).

How many employees does Assertio Holdings have?

Assertio Holdings has 42 employees as of Feb 6, 2024.

Assertio Holdings - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Consumers
  • Enterprise
Main Product
  • Pharmaceuticals
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 14 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 620000Health Care and Social Assistance
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research